Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 470.70
+13.30 (2.91%)
At close: Feb 10, 2026
Renata Market Cap
Renata has a market cap or net worth of 53.99 billion as of February 12, 2026. Its market cap has decreased by -25.66% in one year.
Market Cap
53.99B
Enterprise Value
71.46B
Revenue
44.26B
Ranking
n/a
PE Ratio
21.29
Stock Price
470.70
Market Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 53.99B, an increase of 16,730.55%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 53.99B | 20.14% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 195.91B |
| Beximco Pharmaceuticals PLC. | 54.25B |
| Unilever Consumer Care | 42.71B |
| Beacon Pharmaceuticals | 24.72B |
| The ACME Laboratories | 16.12B |
| The IBN SINA Pharmaceutical Industry | 10.82B |
| Asiatic Laboratories | 8.37B |
| Orion Pharma | 6.95B |